SMAD4, SMAD family member 4, 4089

N. diseases: 575; N. variants: 144
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007130
Disease: Mucinous Adenocarcinoma
Mucinous Adenocarcinoma
0.010 GeneticVariation disease BEFREE The 10 cases of MACA harbored a similar prevalence of TP53 mutations (n=5, 50%) as HAMN but, unlike LAMN and HAMN, some harbored mutations in PIK3CA, APC, FBXW7, PTEN, and SMAD4. 31491041 2020
CUI: C0152427
Disease: Polydactyly
Polydactyly
0.010 GeneticVariation disease BEFREE They both had de novo c.1498A > G (p.Ile500Val) variant in SMAD4 and presented with key characteristics of Myhre syndrome but also revealed uncommon features (polydactyly in the girl and precocious puberty in the boy). 31654632 2020
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.010 Biomarker group BEFREE This study therefore elucidates critical mechanism for IL-21-induced Th17 differentiation to indicate SKI and SMAD4 as potential therapeutic targets for treating autoimmune diseases. 31398665 2019
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.010 GeneticVariation disease BEFREE Four SNPs (rs13381619, rs9955626, rs1792658, and rs1792671) within SMAD2, one SNP within SMAD3 (rs41473580" genes_norm="4087;4088;4089;4092">rs41473580), two SNPs within SMAD4 (rs7229678 and rs9304407), and one SNP within SMAD7 (rs12956924) were significantly associated with susceptibility only to UC. rs13381619 within SMAD2, rs4147358 within SMAD3, rs9304407 within SMAD4, and rs12956924 within SMAD7 exhibited the strongest association (p <  0.001, p =  0.021, p =  0.005, and p =  0.001, respectively). 30653987 2019
CUI: C0017416
Disease: Genital Neoplasms, Female
Genital Neoplasms, Female
0.010 Biomarker group BEFREE A few studies have explored the value of immunohistochemistry for SMAD4 in gynecologic neoplasms, mainly in the ovary. 31569186 2019
CUI: C0018798
Disease: Congenital Heart Defects
Congenital Heart Defects
0.010 Biomarker group BEFREE Through this case report we aim to discuss the pathophysiology of juvenile polyposis syndrome (JPS), highlight what we believe to be a novel presentation of comorbid BMPR1A mutation and ASD and hypothesise that patients with BMPR1A mutation and JPS may be at risk of previously unrecognised cardiovascular complications analogous to the previous association of SMAD4 JPS and cardiac abnormalities. 31229977 2019
CUI: C0018817
Disease: Atrial Septal Defects
Atrial Septal Defects
0.010 GeneticVariation group BEFREE Through this case report we aim to discuss the pathophysiology of juvenile polyposis syndrome (JPS), highlight what we believe to be a novel presentation of comorbid BMPR1A mutation and ASD and hypothesise that patients with BMPR1A mutation and JPS may be at risk of previously unrecognised cardiovascular complications analogous to the previous association of SMAD4 JPS and cardiac abnormalities. 31229977 2019
CUI: C0026499
Disease: Monosomy
Monosomy
0.010 GeneticVariation group BEFREE We also found that aneuploidy (monosomy and polysomy) contributed greatly to how to define chromosomal SMAD4 deletion. 30575147 2019
CUI: C0027831
Disease: Neurofibromatosis 1
Neurofibromatosis 1
0.010 GeneticVariation disease BEFREE The SMAD4 and BMPR1A genes that are involved in 50-60% of JPS cases have not been investigated in the ~ 20 published cases of NF1-associated JLIHMPs with the exception of the abovementioned patient with concomitant JPS and NF1. 30276464 2019
CUI: C0032460
Disease: Polycystic Ovary Syndrome
Polycystic Ovary Syndrome
0.010 AlteredExpression disease BEFREE In contrast to hGLCs from ovulatory ovaries, in PCOS AMH reduced protein levels (cell content) of stimulatory pSMAD-1/5/8 and SMAD-4 but increased inhibitory SMAD-6 and -7 (P < 0.05, normal n = 6, PCOS n = 3). 31735954 2019
CUI: C0033036
Disease: Atrial Premature Complexes
Atrial Premature Complexes
0.010 Biomarker disease BEFREE We sought to study the effect of locally delivered NO on GEM mediated PAC cytotoxicity and the potential role of SMAD4 in this effect. 30790060 2019
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.010 Biomarker disease BEFREE Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling. 31242417 2019
CUI: C0036346
Disease: Schizophrenia, Childhood
Schizophrenia, Childhood
0.010 Biomarker disease BEFREE SMAD4 knockdown (KD) suppressed the production of these BMP inhibitors by SCZ GPCs and rescued normal astrocytic differentiation. 31242417 2019
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.010 Biomarker group BEFREE Loss of Smad4 causes the formation of inappropriate, fragile connections between arteries and veins called arteriovenous malformations (AVMs), which can hemorrhage leading to stroke, aneurysm, or death. 30744395 2019
CUI: C0043124
Disease: West Nile Fever
West Nile Fever
0.010 AlteredExpression disease BEFREE While LGP2 functions to modulate inflammatory signaling, RIG-I and MDA5 together are essential for M1 macrophage polarization in vivo and the control of WNV infection through potential downstream control of ATF4 and SMAD4 to regulate target gene expression for cell polarization. 31409781 2019
CUI: C0340643
Disease: Dissection of aorta
Dissection of aorta
0.010 Biomarker disease BEFREE The expression of SMAD4 was modulated by miR-146a-5p. miR-146a-5p induced VSMC proliferation and migration through targeting SMAD4 and hence might be potentially involved in the development of AD. 30779466 2019
CUI: C0349579
Disease: Atypical Endometrial Hyperplasia
Atypical Endometrial Hyperplasia
0.010 Biomarker disease BEFREE Our findings show a potential diagnostic role of this microRNAs signature for the accurate diagnosis of Endometrial hyperplasia with atypia/Endometrial Intraepithelial Neoplasia and improve the understanding of their pivotal role in SMAD4 regulation. 31293968 2019
CUI: C0879615
Disease: Stromal Neoplasm
Stromal Neoplasm
0.010 Biomarker disease BEFREE In this study, we demonstrate that in PDAC SMAD4 status and tumor stromal content can be predicted using radiomic analysis of preoperative CT imaging. 31243486 2019
Endometrial intraepithelial neoplasia
0.010 Biomarker disease BEFREE Our findings show a potential diagnostic role of this microRNAs signature for the accurate diagnosis of Endometrial hyperplasia with atypia/Endometrial Intraepithelial Neoplasia and improve the understanding of their pivotal role in SMAD4 regulation. 31293968 2019
CUI: C1704274
Disease: Intrauterine adhesions
Intrauterine adhesions
0.010 Biomarker disease BEFREE In addition, the injection of si-KDR increased the number of endometrial glands, reduced the area of fibrosis, inhibited mRNA and protein expression of KDR and VEGF, up-regulated the expression of MMP-9 and Smad7, and decreased the expression level of TGF-β1, p-Smad2, p-Smad3, and Smad4 in rats with IUA. 31596310 2019
CUI: C1969372
Disease: Tubulointerstitial fibrosis
Tubulointerstitial fibrosis
0.010 Biomarker phenotype BEFREE In summary, our data showed that autophagy in FOXD1-lineage stromal cells plays a protective role in renal TIF through regulating the Smad4 dependent TGF-β an NLRP3 inflammasome signaling pathway. 30545632 2019
CUI: C4045991
Disease: Perihilar Cholangiocarcinoma
Perihilar Cholangiocarcinoma
0.010 AlteredExpression disease BEFREE Large-duct iCCA and pCCA more frequently had the loss of SMAD4 expression and MDM2 amplifications than small-duct iCCA, whereas the loss of BAP1 expression and IDH1 mutations were mostly restricted to small-duct iCCA. 30170977 2019
CUI: C4531084
Disease: Mucinous colorectal carcinoma
Mucinous colorectal carcinoma
0.010 Biomarker disease BEFREE Accordingly, KRAS (12/17, 70.6%), APC (6/17, 35.3%), SMAD4, TP53 (4/17, 23.5%, each), PIK3CA (3/17, 17.6%), AKT1, ATM, BRAF, EGFR, and EZH2 (1/17, 5.9%, each) were altered in MC. 31400926 2019
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2
0.010 GeneticVariation disease BEFREE Based on the clinical overlap of CM-AVM2 and HHT, we hypothesized that patients considered clinically suspicious for HHT with no variant detected in an HHT gene (ENG, ACVRL1, or SMAD4) may have an EPHB4 variant. 30760892 2019
CUI: C0002793
Disease: Anaplasia
Anaplasia
0.010 Biomarker disease BEFREE These results indicate that SMAD4 functions to maintain differentiated enterocytes in the presence of oncogenic WNT signaling, thus preventing dedifferentiation and tumor formation in the differentiated intestinal epithelium.<b>Significance:</b> This work identifies a mechanism through which differentiated cells prevent tumor formation by suppressing oncogenic plasticity.<i></i>. 29986996 2018